Oscient’s Factive To Get Advisory Committee Review For Acute Bacterial Sinusitis
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Anti-Infective Drugs Advisory Committee will review Oscient’s sNDA for the antibiotic Sept. 12.